Clinical Trial Update: Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Lovaza (omega-3-acid ethyl esters) in recurrent, symptomatic atrial fibrillation completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• LOVAZA (OMEGA-3-ACID ETHYL ESTERS)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Fibrillation, Atrial | Phase 3 | Status: COMPLETED | Results posted: 2010-10-15